Ekkehard Q. Haen
Pentling, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.
Journal: Pharmacopsychiatry
Published: July 02, 2026
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson's Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis.
Journal: Pharmacopsychiatry
Published: April 17, 2025
Effects of the augmentation with quetiapine or olanzapine on the metabolism of duloxetine: a retrospective analysis.
Journal: Expert review of clinical pharmacology
Published: March 31, 2025
Aggregation suppression and enhanced blue emission of perylene in zinc-based coordination polymer glass.
Journal: Chemical communications (Cambridge, England)
Published: January 29, 2025
Pharmacokinetic interaction of quetiapine and lamotrigine - victim and perpetrator?
Journal: Expert review of clinical pharmacology
Published: October 03, 2024
Nifedipine May Be an Inhibitor of Clozapine Metabolism as Seen in 5 Patients: 2 From a US Double-Blind Study and 3 From a German Therapeutic Drug Monitoring Study.
Journal: Therapeutic drug monitoring
Published: August 04, 2024
Pharmacokinetic correlates of clinical response in a naturalistic sample of escitalopram-treated patients.
Journal: Expert review of clinical pharmacology
Published: February 01, 2024
Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions.
Journal: Therapeutic drug monitoring
Published: July 25, 2023
Last Updated: 09/26/2026